I'm a big fan of Amplify and they have been incredible partners to work with throughout our entire time building compound and my sense is founders feel the same. Congrats to the whole team! https://t.co/ySAiP8Xgj0
We started Amplify Partners with one goal: to help technical founders turn deeply technical ideas into enduring, category-defining businesses. Today, we’re proud to share that we’ve raised $900M across three new funds to keep doing just that. https://t.co/BqvPk8EWCm
New funds, new look, same Amplify. Announcing our $900M 6th set of funds, our first ever digital bio fund, and our new logo and site. The first (and best) investor for technical founders. https://t.co/RUlzq5hBRi
Amplify Partners, a Silicon Valley venture capital firm, has raised $200 million for its first biotech-specific fund aimed at investing in pre-seed, seed, and Series A-stage startups. The fund targets approximately 20 investments ranging from $1.5 million to $10 million. In conjunction with this new fund, Amplify has appointed Elliot Hershberg as a partner to lead early-stage biotech investments. Additionally, Amplify announced the closing of $900 million across three new funds, including its first digital biology fund, accompanied by a rebranding featuring a new logo and website. The firm continues to focus on supporting technical founders in developing deeply technical ideas into category-defining businesses.